Changes of Optical Quality During the Peak of the Covid-19 Pandemic
- Conditions
- SARS-CoV-2Corneal Wavefront Aberration
- Registration Number
- NCT05882383
- Lead Sponsor
- Tianjin Eye Hospital
- Brief Summary
To explore whether cornea structure, and optical quality are affected by the covid-19 infection.
- Detailed Description
Participants with healthy corneas admitted to Tianjin Eye Hospital from November 25 to January 20, 2022 were followed up . At the end of the follow-up, the investigators recorded in detail whether the patients had undergone real-time reverse transcriptase polymerase chain reaction (covid-19 RT-PCR tests) testing, testing time and results. The presence of PCR-positive during follow-up is considered to be covid-19 infection; PCR-Negative and no symptoms of infection during the follow-up period are considered not infected; participants with symptoms but no PCR test were excluded from the study.Participants were divided into three groups according to the RT-PCR results and the presence or absence of symptoms of infection during follow-up. pentacam (Pentacam HR, Oculus, Wetzlar, Germany) was performed during follow-up and the results were recorded,and the data was statistically managed and compared.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 110
Not provided
- corneal disease;
- ocular trauma;
- Pregnant and lactating women;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The value of cornea thickness 1 months The value of cornea thickness from pentacam during follow-up were compared, includig the thinnest point, apex of the cornea.
The value of cornea backscatter 1 months The value of cornea backscatter from pentacam during follow-up were compared, including anterior layer,central layer and posterior
The value of cornea aberration 1 months The value of aberration data from pentacam during follow-up were compared, including coma, spherical aberration, defocus, and astigmatism
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Tianjin Eye Hospital
🇨🇳Tianjin, Tianjin, China